Gainers
$Cardiff Oncology(CRDF.US)$ rose 17.3% to $8.27 in pre-market trading after the company announced new data from its Phase 1b/2 trial in KRAS-mutated metastatic colorectal cancer showing "robust objective response rate and progression free survival."
$TSR Inc(TSRI.US)$ rose 15.7% to $12.82 in pre-market trading. The company, last month, said it swung to a quarterly loss.
$GOLD ROYALTY CORP(GROY.US)$ rose 15.1% to $4.74 in pre-market trading. Gold Royalty, Abitibi Royalties and Golden Valley recently announced plans to combine to create a leading growth and Americas-focused precious metals royalty company.
$ProQR Therapeutics NV(PRQR.US)$ rose 15% to $7.83 in pre-market trading after the company announced Axiomer RNA editing licensing and research collaboration with Lilly.
$Lululemon Athletica(LULU.US)$ shares rose 13.3% to $431.66 in pre-market trading after the company reported better-than-expected Q2 results and issued strong Q3 revenue guidance.
$Torrid Holdings(CURV.US)$ rose 12.7% to $20.81 in pre-market trading after the company reported better-than-expected Q2 results.
$VPC IMPACT ACQUISITION HLDGS(VIH.US)$ shares rose 5.7% to $10.95 in pre-market trading after declining around 6% on Wednesday.
Losers
$Humanigen Inc(HGEN.US)$ shares fell 54.5% to $6.87 in pre-market trading after the company disclosed that the FDA has declined its request for emergency use authorization of lenzilumab in hospitalized patients.
$HELBIZ INC(HLBZ.US)$ shares fell 21.1% to $10.26 in pre-market trading after jumping 84% on Wednesday. Helbiz launched a fleet of 150 e-scooters in Durham, North Carolina, after securing a one-year permit.
$Couchbase, Inc.(BASE.US)$ shares fell 16.6% to $43.00 in pre-market trading after the company reported a wider loss for its second quarter.
$Certara(CERT.US)$ shares fell 8.2% to $32.26 in pre-market trading after the company reported pricing of public offering of common stock.
$Boston Beer(SAM.US)$ fell 8.1% to $514.00 in pre-market trading after the company announced it withdrew 2021 financial guidance.
$GameStop(GME.US)$ fell 7.6% to $183.65 in pre-market trading after the company reported wider-than-expected Q2 loss.
$EFFECTOR THERAPEUTICS INC(EFTR.US)$ fell 7.6% to $25.12 in pre-market trading after surging around 112% on Wednesday.
$NetEase(NTES.US)$ fell 7.1% to $84.30 in pre-market trading on renewed industry concerns in China.
$Mechel PAO(MTL.US)$ fell 7% to $4.12 in pre-market trading after tumbling over 11% on Wednesday. The company recently reported Q2 results, including a 43% quarter-over-quarter revenue growth.
$Forte Biosciences Inc(FBRX.US)$ fell 7% to $3.86 in pre-market trading. Forte Biosciences recently announced the clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical significance.
$HUYA Inc.(HUYA.US)$ shares fell 6.5% to $10.14 in pre-market trading. HUYA’s CFO Catherine Xiaozheng Liu resigned for personal reasons, effective September 8, 2021.
$Bilibili(BILI.US)$ fell 6.1% to $80.60 in pre-market trading amid concerns.
$DouYu International(DOYU.US)$ shares fell 5% to $3.80 in pre-market trading after dropping over 6% on Wednesday. The company’s board recently authorized a share buyback program of up to $100 million of its ordinary shares.